The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 15, 2016

Filed:

Dec. 03, 2010
Applicants:

Ellen Umlauf, Vienna, AT;

Maria Zellner, Vienna, AT;

Inventors:

Ellen Umlauf, Vienna, AT;

Maria Zellner, Vienna, AT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/68 (2006.01); C07K 14/47 (2006.01); C07K 14/775 (2006.01); C12N 9/06 (2006.01); C12N 9/10 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07K 14/47 (2013.01); C07K 14/4716 (2013.01); C07K 14/775 (2013.01); C12N 9/0022 (2013.01); C12N 9/1044 (2013.01); G01N 2333/775 (2013.01); G01N 2333/90638 (2013.01); G01N 2333/91085 (2013.01); G01N 2800/2821 (2013.01);
Abstract

The present invention provides an ex vivo method for aiding the diagnosis of Alzheimer's disease in a patient, the method comprising the steps of determining the level of expression of at least four platelet proteins in a platelet sample from the patient selected from monoamine oxidase-B, coagulation factor Xllla, total tropomyosin (a and 13), WD-repeat protein 1 and apolipoprotein E4; and comparing the result of (i) to a control value, wherein a result higher than the control value is indicative of Alzheimer's disease. Preferably, the method of the invention further comprises determining the level of expression of wild-type GSTO-1 or mutant GSTO-1.


Find Patent Forward Citations

Loading…